Caplin Point Laboratories has informed that it enclosed a Press Release regarding acquisition of ten approved Abbreviated New Drug Applications (ANDAs) for Injectable and Opthalmic products from a leading Multinational Generic product manufacturing company.
The above information is a part of company’s filings submitted to BSE.